Mostrando resultados 151 a 170 de 234
< Anterior
Siguiente >
Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![Personality and psychiatric disorders in chronic pain male affected.pdf.jpg](/jspui/retrieve/7cce012c-d596-46f4-97fd-a125c9de19e0/Personality%20and%20psychiatric%20disorders%20in%20chronic%20pain%20male%20affected.pdf.jpg) | may-2020 | Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study | Ajo Ferrer, Raquel; Inda, Maria del Mar; Mateu, Margarita; Segura, Ana; Ballester, Pura; Muriel, Javier; Sellers, Rafael; Ferrández, Guillermina; Margarit, César; Peiró, Ana | ![](/image/closedAccess.png) |
![Personalized medicine into health national.pdf.jpg](/jspui/retrieve/835f90ed-3e0a-463e-8c9f-b70e0e3bd957/Personalized%20medicine%20into%20health%20national.pdf.jpg) | 19-dic-2018 | Personalized medicine into health national services: barriers and potentialities | Rodríguez-Vicente, Ana E; Herrero Cervera, Maria José; Bernal, María Luisa; Rojas, Luis; Peiró, Ana | ![](/image/openAccess.png) |
![Ortiz Marcos, Carlos.pdf.jpg](/jspui/retrieve/68c71f77-e13e-40df-8bbf-fd05a1f014f3/Ortiz%20Marcos%2c%20Carlos.pdf.jpg) | 19-may-2022 | Perspectivas terapéuticas en el tratamiento del Trastorno por Déficit de Atención e Hiperactividad (TDAH) con fitocannabinoides. | Ortiz Marcos, Carlos | ![](/image/openAccess.png) |
![Pharmacogenetic Guided Opioid Therapy Improves Chronic.pdf.jpg](/jspui/retrieve/1772878b-270e-4cd7-bc03-a7cb5fee6471/Pharmacogenetic%20Guided%20Opioid%20Therapy%20Improves%20Chronic.pdf.jpg) | 2023 | Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study | Agulló, Laura; Aguado, Isidro; Muriel, Javier; Margarit, César; Gómez, Alba; Escorial, Mónica; Sánchez, Astrid; Fernández, Alicia; Peiró, Ana | ![](/image/openAccess.png) |
![Pharmacogenetics and prediction of adverse events in.pdf.jpg](/jspui/retrieve/57275c95-8b6e-4e03-a7db-9b305d1d5d13/Pharmacogenetics%20and%20prediction%20of%20adverse%20events%20in.pdf.jpg) | 2018 | Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Barrachina, Jordi; Ballester, Pura; Flor, Andrea; Morales, Domingo; Horga, José F.; Fernández, Eduardo; Peiró, Ana | ![](/image/closedAccess.png) |
![DE MIGUEL LÓPEZ, LAURA, TFG.pdf.jpg](/jspui/retrieve/1ec1c55f-351f-4095-bdf2-103c567fd7df/DE%20MIGUEL%20L%c3%93PEZ%2c%20LAURA%2c%20TFG.pdf.jpg) | 3-may-2023 | Pharmacogenetics for psychotropic drugs and a cross-sectional study of adverse events in autism spectrum disorder | de Miguel López, Laura | ![](/image/openAccess.png) |
![Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder. An Observational Pilot Study.pdf.jpg](/jspui/retrieve/8e029221-b410-4198-8f90-2cc542393bc7/Pharmacogenetics%20May%20Prevent%20Psychotropic%20Adverse%20Events%20in%20Autism%20Spectrum%20Disorder.%20An%20Observational%20Pilot%20Study.pdf.jpg) | 20-oct-2023 | Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study | Miguel, Laura de; Ballester, Pura; Egoavil, Cecilia; Sánchez-Ocaña, María Luisa; García-Muñoz, Ana María; Cerdá, Begoña; ZAFRILLA, PILAR; Ramos, Enrique; Peiró, Ana | ![](/image/openAccess.png) |
![Pharmacogenomics and prescription opioid.pdf.jpg](/jspui/retrieve/96d89889-1a3a-47f7-aff1-9f9fe20e0425/Pharmacogenomics%20and%20prescription%20opioid.pdf.jpg) | mar-2021 | Pharmacogenomics and prescription opioid use | Benjeddou, Mongi; Peiró, Ana | ![](/image/closedAccess.png) |
![TFG FINAL Rym Feryal Amara.pdf.jpg](/jspui/retrieve/2397d7e6-b118-40c2-9485-e2dcc09689a4/TFG%20FINAL%20Rym%20Feryal%20Amara.pdf.jpg) | 18-ago-2023 | Posibles aspectos terapéuticos de los cannabinoides en el dolor neuropático: Revisión de alcance. | Amara Hadj Messaoud, Rym Feryal | ![](/image/openAccess.png) |
![Daniel Carretero Moraleda-TFG.pdf.jpg](/jspui/retrieve/a1acdc80-5988-4f22-9bee-28a66e9da6b4/Daniel%20Carretero%20Moraleda-TFG.pdf.jpg) | 24-may-2023 | Potencial terapéutico del cannabidiol en la enfermedad de Parkinson | Carretero Moraleda, Daniel | ![](/image/openAccess.png) |
![TFG_ÁlvaroPuertasCaruana.pdf.jpg](/jspui/retrieve/621b8777-dea8-4f8b-ab05-1f1d21aa2138/TFG_%c3%81lvaroPuertasCaruana.pdf.jpg) | 17-may-2023 | Potencial utilidad del cannabidiol en la abstinencia inducida por el consumo de cannabis | Puertas Caruana, Álvaro | ![](/image/openAccess.png) |
![2020 7 DAP MONTES.pdf.jpg](/jspui/retrieve/44c6990e-3e75-44a6-aea8-63c99d648d86/2020%207%20DAP%20MONTES.pdf.jpg) | 2020 | Presurgical risk model for chronic postsurgical pain
based on 6 clinical predictors: a prospective
external validation | Montes, Antonio; Roca, Gisela; Cantillo, Jordi; Sebate, Sergi | ![](/image/closedAccess.png) |
![JOSE ANTONIO VICENTE MATEO.pdf.jpg](/jspui/retrieve/5494fdba-03d5-4f52-a13d-f835ec2cbd30/JOSE%20ANTONIO%20VICENTE%20MATEO.pdf.jpg) | 3-jun-2021 | Progresos en la síntesis de (S)-clopidogrel | Vicente Mateo, José Antonio | ![](/image/openAccess.png) |
![Quadrupolar Ultrafast Charge Transfer in.pdf.jpg](/jspui/retrieve/8c3564d0-52f6-40b5-9afe-dbeb54fec58a/Quadrupolar%20Ultrafast%20Charge%20Transfer%20in.pdf.jpg) | 2022 | Quadrupolar Ultrafast Charge Transfer in Diaminoazobenzene-Bridged Perylenediimide Triads | Seetharaman, Sairaman; Zink Lorre, Nathalie; Gutiérrez Moreno, David; Karr, Paul A.; Fenández-Lázaro, Fernando; D’Souza, Francis | ![](/image/closedAccess.png) |
![Randomized, Controlled, Crossover Study of.pdf.jpg](/jspui/retrieve/46dd496f-573d-43ea-b754-2568e08dd6ca/Randomized%2c%20Controlled%2c%20Crossover%20Study%20of.pdf.jpg) | nov-2018 | Randomized, Controlled, Crossover Study of Self-administered Jacobson Relaxation in Chronic, Nonspecific, Low-back Pain | Mateu, Margarita; ALDA, OLGA; Inda, María del Mar; Margarit, César; Ajo Ferrer, Raquel; Morales, Domingo; Van-der Hofstadt, Carlos; Peiró, Ana | ![](/image/openAccess.png) |
![Relación entre variables fisio-patológicas y las concentraciones plasmáticas de adalimumab en pacientes con enfermedad inflamatoria intestinal.pdf.jpg](/jspui/retrieve/73ef676c-07a2-4fb0-8f7e-e92bd5fa1263/Relaci%c3%b3n%20entre%20variables%20fisio-patol%c3%b3gicas%20y%20las%20concentraciones%20plasm%c3%a1ticas%20de%20adalimumab%20en%20pacientes%20con%20enfermedad%20inflamatoria%20intestinal.pdf.jpg) | 3-may-2023 | Relación entre variables fisio-patológicas y las concentraciones plasmáticas de adalimumab en pacientes con enfermedad inflamatoria intestinal | Carrascosa Arteaga, Ana | ![](/image/openAccess.png) |
![MARTÍNEZ LUJÁN, CARMEN .pdf.jpg](/jspui/retrieve/a32e83bf-d607-4a16-a7ab-54206d61e5cd/MART%c3%8dNEZ%20LUJ%c3%81N%2c%20CARMEN%20.pdf.jpg) | 24-may-2022 | Respuesta inmune frente a nemátodos intestinales | Martínez Luján, Carmen | ![](/image/openAccess.png) |
![TFG Inmaculada Murcia Fabra.pdf.jpg](/jspui/retrieve/5c55d9c6-30c1-42dd-957c-cb83e32491aa/TFG%20Inmaculada%20Murcia%20Fabra.pdf.jpg) | 20-may-2022 | Revisión bibliográfica de las reacciones adversas por excipientes que se encuentran en las vacunas para la COVID-19 y el uso de pruebas diagnósticas | Murcia Fabra, Inmaculada | ![](/image/openAccess.png) |
![PérezMiguelAndrea_TFG.pdf.jpg](/jspui/retrieve/5cbcd6e4-fe07-408b-bb5b-1ba1aa077f08/P%c3%a9rezMiguelAndrea_TFG.pdf.jpg) | 24-may-2023 | Revisión bibliográfica sobre el intercambio terapéutico de anticuerpos monoclonales anti-CGRP en migraña | Pérez Miguel, Andrea | ![](/image/openAccess.png) |
![Santonja Faes, Carlos TFG.pdf.jpg](/jspui/retrieve/b711507d-190f-403d-ade6-2392108627c7/Santonja%20Faes%2c%20Carlos%20TFG.pdf.jpg) | 1-feb-2023 | Revisión bibliográfica sobre la eficacia y seguridad de los análogos de GLP-1 como tratamiento para la
pérdida de peso en pacientes obesos | Santonja Faes, Carlos | ![](/image/openAccess.png) |